AlphaCrest Capital Management’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,664
Closed -$2.86M 1083
2022
Q3
$2.86M Buy
5,664
+4,689
+481% +$2.47M 0.17% 113
2022
Q2
$501K Sell
975
-1,509
-61% -$758K 0.02% 956
2022
Q1
$1.27M Sell
2,484
-996
-29% -$480K 0.07% 438
2021
Q4
$1.75M Sell
3,480
-14,268
-80% -$6.46M 0.06% 499
2021
Q3
$6.93M Sell
17,748
-12,402
-41% -$5.14M 0.36% 24
2021
Q2
$12.1M Buy
30,150
+29,098
+2,766% +$11.6M 0.52% 8
2021
Q1
$391K Sell
1,052
-1,761
-63% -$610K 0.02% 915
2020
Q4
$986K Sell
2,813
-6,142
-69% -$2.06M 0.08% 324
2020
Q3
$2.79M Buy
8,955
+7,880
+733% +$2.42M 0.3% 50
2020
Q2
$317K Sell
1,075
-5,484
-84% -$1.57M 0.05% 601
2020
Q1
$1.64M Buy
6,559
+2,562
+64% +$705K 0.2% 121
2019
Q4
$1.18M Sell
3,997
-31,826
-89% -$8.33M 0.1% 274
2019
Q3
$7.79M Buy
35,823
+20,622
+136% +$4.98M 0.47% 9
2019
Q2
$3.71M Buy
15,201
+5,584
+58% +$1.34M 0.32% 41
2019
Q1
$2.38M Buy
9,617
+7,696
+401% +$1.96M 0.36% 35
2018
Q4
$479K Buy
+1,921
New +$507K 0.14% 258

Other funds holding UNH

AlphaCrest Capital Management's UNH Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of UnitedHealth (UNH) in Q4 2022, closing a stake of 5,664 shares — an estimated $2.86M sold.

AlphaCrest Capital Management first reported a position in UNH in Q4 2018 and held it in 16 quarters. The position peaked at $12.1M in Q2 2021. 3,156 funds tracked by Wall St. Rank hold UNH as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining UnitedHealth position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 5,664 UnitedHealth shares in Q4 2022, an estimated $2.86M.
  • AlphaCrest Capital Management first reported a position in UnitedHealth in Q4 2018 and held it in 16 quarters.
  • AlphaCrest Capital Management's UnitedHealth position peaked at $12.1M in Q2 2021.
  • 3,156 funds tracked by Wall St. Rank held UnitedHealth as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.